Schrodinger (SDGR) Stock Price, News & Analysis

Company Overview

Schrödinger, Inc. develops computational software designed to accelerate drug discovery and materials science research. Its platform uses physics-based modeling, machine learning and related computational methods to help scientists analyze molecular structures, predict interactions and identify potential compounds for further development.

The company’s software products support a range of research activities, including molecular modeling, virtual screening, structure-based drug design, free-energy calculations and collaborative data management. Its offerings include the Maestro molecular modeling environment, the LiveDesign collaborative platform and specialized tools such as Glide and FEP+. Schrödinger provides these technologies to pharmaceutical, biotechnology, chemical and materials companies, as well as academic and government research organizations.

In addition to selling software and providing related services, Schrödinger applies its computational platform to internal drug discovery programs and collaborates with pharmaceutical and biotechnology companies. The company serves customers internationally and is headquartered in New York City. Schrödinger was founded in 1990 and is led by President and Chief Executive Officer Ramy Farid.

Key Stats

• Today's Range: $28.32 to $31.14
• 50-Day Range: $14.97 to $30.70
• 52-Week Range: $10.94 to $31.59
• Volume: 3.07 million shs
• Average Volume: 1.94 million shs
• Market Capitalization: $2.16 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $20.50
• Consensus Rating: Hold

Schrodinger Stock Analysis - MarketRank™

Schrodinger scored higher than 26% of companies evaluated by MarketBeat, and ranked 803rd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Hold

Consensus Rating

Schrodinger has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 3 buy ratings, 3 hold ratings, and 1 sell rating.

Downside Risk

Schrodinger has a consensus price target of $20.50, representing about 29.9% downside from its current price of $29.23.

Amount of Analyst Coverage

Schrodinger has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Schrodinger are expected to grow in the coming year, from ($1.50) to ($1.10) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Schrodinger is -39.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Schrodinger is -39.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Schrodinger has a P/B Ratio of 5.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.71% of the float of Schrodinger has been sold short.

Short Interest Ratio / Days to Cover

Schrodinger has a short interest ratio ("days to cover") of 11.76, which indicates bearish sentiment.

Change versus previous month

Short interest in Schrodinger has recently decreased by 2.95%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Schrodinger does not currently pay a dividend.

Dividend Growth

Schrodinger does not have a long track record of dividend growth.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 0.62

News Sentiment

Schrodinger has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Schrodinger this week, compared to 3 articles on an average week.

Search Interest

5 people have searched for SDGR on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.

MarketBeat Follows

6 people have added Schrodinger to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Schrodinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $928,063.00 in company stock.

Percentage Held by Insiders

10.10% of the stock of Schrodinger is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

79.05% of the stock of Schrodinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 9/23/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:SDGR
• CIK: 1490978
• Web: www.schrodinger.com
• Phone: 212-295-5800
• Fax: N/A
• Employees: 850
• Year Founded: 1990

Price Target and Rating

• Average Price Target for Schrodinger: $20.50
• High Price Target: $24.00
• Low Price Target: $17.00
• Potential Upside/Downside: -29.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.29
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.74)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$103.26 million
• Net Margins: -20.98%
• Pretax Margin: -20.05%
• Return on Equity: -16.37%
• Return on Assets: -8.19%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.71
• Quick Ratio: 2.71

Sales & Book Value

• Annual Sales: $255.87 million
• Price / Sales: 8.43
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.94 per share
• Price / Book: 5.92

Miscellaneous

• Outstanding Shares: 73,820,000
• Free Float: 66,369,000
• Market Cap: $2.16 billion
• Optionable: Optionable
• Beta: 1.69